Browse our anti-Chromogranin A (CHGA) Antibodies

Full name:
anti-Chromogranin A Antibodies (CHGA)
On www.antibodies-online.com are 733 Chromogranin A (CHGA) Antibodies from 37 different suppliers available. Additionally we are shipping Chromogranin A Kits (73) and Chromogranin A Proteins (31) and many more products for this protein. A total of 878 Chromogranin A products are currently listed.
Synonyms:
cgA, CHGA, ChrA, fj05f09, si:dkey-177p2.2, wu:fj05f09, zgc:56075, zgc:101749
list all antibodies Gene Name GeneID UniProt
CHGA 12652 P26339
CHGA 1113 P10645
Anti-Rat CHGA CHGA 24258  

Show all species

Show all synonyms

Most Popular Reactivities for anti-Chromogranin A (CHGA) Antibodies

Select your species and application

anti-Mouse (Murine) Antibodies:

anti-Human Antibodies:

anti-Rat (Rattus) Antibodies:

All available anti-Chromogranin A Antibodies

Go to our pre-filtered search.

Top referenced anti-Chromogranin A Antibodies

  1. Human Monoclonal CHGA Primary Antibody for IHC (p) - ABIN1687807 : Liang, Chen, Wang, Jin, Zhang, Yan, Zhang, Wang: A retrospective analysis of the clinicopathological characteristics of large cell carcinoma of the lung. in Experimental and therapeutic medicine 2014 (PubMed)
    Show all 8 references for 1687807

  2. Human Polyclonal CHGA Primary Antibody for ICC, IF - ABIN266232 : Polyak, Mach, Porvasnik, Dixon, Conlon, Erger, Acosta, Wright, Campbell-Thompson, Zolotukhin, Wasserfall, Mah: Identification of adeno-associated viral vectors suitable for intestinal gene delivery and modulation of experimental colitis. in American journal of physiology. Gastrointestinal and liver physiology 2012 (PubMed)
    Show all 8 references for 266232

  3. Human Monoclonal CHGA Primary Antibody for IHC (p) - ABIN1687845 : Hijioka, Hosoda, Mizuno, Hara, Imaoka, Bhatia, Mekky, Tajika, Tanaka, Ishihara, Yogi, Tsutumi, Fujiyoshi, Sato, Hieda, Yoshida, Okuno, Shimizu, Yatabe, Niwa, Yamao: Does the WHO 2010 classification of pancreatic neuroendocrine neoplasms accurately characterize pancreatic neuroendocrine carcinomas? in Journal of gastroenterology 2015 (PubMed)
    Show all 5 references for 1687845

  4. Human Polyclonal CHGA Primary Antibody for IF (cc), IF (p) - ABIN669846 : Wang, Ahmad, Shah, Sims, Magness, Allbritton: Capture and 3D culture of colonic crypts and colonoids in a microarray platform. in Lab on a chip 2013 (PubMed)
    Show all 5 references for 669846

  5. Human Monoclonal CHGA Primary Antibody for EIA, IHC (fro) - ABIN1106699 : Wen, Mahata, Cadman, Mahata, Ghosh, Mahapatra, Rao, Stridsberg, Smith, Mahboubi, Schork, OConnor, Hamilton: Both rare and common polymorphisms contribute functional variation at CHGA, a regulator of catecholamine physiology. in American journal of human genetics 2004 (PubMed)
    Show all 2 references for 1106699

  6. Cow (Bovine) Polyclonal CHGA Primary Antibody for WB - ABIN2777071 : Leibovitch, Pinthus, Sella, Ramon: [Plasma chromogranin-A (CgA)--a potential marker for diagnosis, monitoring and management of prostate cancer patients]. in Harefuah 2006 (PubMed)

  7. Human Polyclonal CHGA Primary Antibody for ELISA, WB - ABIN185645 : Li, Yuan, Lu, Xia, Zhu, Zhang, Qiao: Treatment of pancreatic carcinoma by adenoviral mediated gene transfer of vasostatin in mice. in Gut 2006 (PubMed)

  8. Human Polyclonal CHGA Primary Antibody for IHC (fro), IHC (p) - ABIN115294 : Koslov, Maupin, Pradhan, Morrow, Rimm: Alpha-catenin can form asymmetric homodimeric complexes and/or heterodimeric complexes with beta-catenin. in The Journal of biological chemistry 1997 (PubMed)

More Antibodies against Chromogranin A Interaction Partners

Zebrafish Chromogranin A (CHGA) interaction partners

  1. Study indicates that chga may play an important role in nervous system development during the early embryonic stages.

Mouse (Murine) Chromogranin A (CHGA) interaction partners

  1. Increased myocardial CgA (show CGA Antibodies) glycosylation and impaired CgA (show CGA Antibodies) processing to catestatin in heart failure be considered detrimental because CST (show CORT Antibodies) reduces diastolic Ca2 (show CA2 Antibodies)+ leak via direct CaMKIIdelta inhibition.

  2. performance of CgA (show CGA Antibodies)-deficient Chga-KO mice in treadmill exercise was impaired. CgA (show CGA Antibodies) deficiency renders the muscle energy deficient, impairs performance in treadmill exercise and prevents regeneration after exercise-induced tissue damage.

  3. dilated mitochondrial cristae, endoplasmic reticulum and Golgi complex, as well as increased synaptic mitochondria, synaptic vesicles and glycogen (show GYS1 Antibodies) granules in Chga-knockout mice compared to WT mice.

  4. the presence of ChgA and subsequent activation of ChgA-reactive T cells are essential for the initiation and development of autoimmune diabetes in NOD mice.

  5. Studied leptin (show LEP Antibodies) and CST (show CORT Antibodies) modulation of SGLT1 (show SLC5A1 Antibodies) expression in hyperleptinemic type 2 diabetic mice.

  6. N-terminal additions to the WE14 peptide of chromogranin A create strong autoantigen agonists in type 1 diabetes.

  7. Data indicate that T-cell receptors that react to chromogranin A (ChgA) and islet amyloid polypeptide (show IAPP Antibodies) precursor (IAPP (show IAPP Antibodies)) autoantigens were impaired when the thymic stromal cells lacked thymus-specific serine protease (TSSP (show PRSS16 Antibodies)).

  8. the important roles of CgA and CgB in glucose and cardiovascular homeostasis. This study also unveils the existence of direct implications of Cgs in the control of behaviour and mood.

  9. Chromogranin A (10-19) and chromogranin A (43-52) were identified as antigens for autoreactive CD8 (show CD8A Antibodies)(+) T cells in NOD.beta2m(null).HHD (show ATP2C1 Antibodies) mice.

  10. Report QT/heart rate variability in a genomically "humanized" chromogranin a monogenic mouse model with hyperadrenergic hypertension.

Human Chromogranin A (CHGA) interaction partners

  1. Combined plasma CgA (show CGA Antibodies) concentrations and World Health Organization grading may assist in better stratification of PNET patients in terms of the risk of recurrence.

  2. Metastatic castration-resistant prostate cancer patients with an early high CGA (show CGA Antibodies) rise may demonstrate a subgroup with poor outcome due to underlying small cell/neuroendocrine cell transformation.

  3. genetic association studies in population in India: Data suggest that common polymorphisms (SNPs) in CHGA promoter are associated with cardiometabolic disorders; c-Rel (show NFkBP65 Antibodies) has a role in activating CHGA promoter haplotype 2 (variant T alleles at -1018 and -57 bp) under basal and pathophysiological conditions. (CHGA = chromogranin A; c-Rel (show NFkBP65 Antibodies) = c-Rel proto-oncogene protein)

  4. Multivariate analyses of nonfunctional pancreatic neuroendocrine tumor patients with both grade and CgA (show CGA Antibodies) recorded found poorly differentiated tumors and very high CgA (show CGA Antibodies) negatively impacted survival.

  5. High chromogranin A expression is associated with neuroendocrine differentiation in colorectal cancer.

  6. Plasma catestatin was associated with coronary collateral developments, suggesting a useful biomarker for coronary collateral development and potential target for therapeutic angiogenesis in patients with coronary artery chronic total occlusions (CTO (show ATP6V0D1 Antibodies)).

  7. Increased myocardial CgA (show CGA Antibodies) glycosylation and impaired CgA (show CGA Antibodies) processing to catestatin in heart failure be considered detrimental because CST (show GAL3ST1 Antibodies) reduces diastolic Ca2 (show CA2 Antibodies)+ leak via direct CaMKIIdelta inhibition.

  8. Data suggest pancreastatin, a 49 residue post-translational fragment of chromogranin A, as a routinely tested biomarker in neuroendocrine tumors (NETs) and in particular small bowel NET.

  9. Data indicate that measurement of chromogranin A (CgA) alone is sufficient in the management of patients with neuroendocrine tumours (NETs) and that routine additional measurement of chromogranin B (CgB (show CHGB Antibodies)) provides little added value.

  10. Data show that chrysin suppressed cell proliferation and reducing expression of achaete-scute complex-like 1 (ASCL1 (show ASCL1 Antibodies)) and the neuroendocrine biomarker chromogranin A (CgA).

Pig (Porcine) Chromogranin A (CHGA) interaction partners

  1. High pancreastatin levels are significantly associated with neuroendocrine tumors.

  2. No circadian pattern was detected for salivary CgA in either spring or autumn, and there were no significant effects of gender or age. However, mean salivary CgA concentrations were significantly higher in the pigs sampled in autumn, compared to spring.

  3. expression and localization of chromogranin A (CgA), chromogranin B (CgB (show CHGB Antibodies)), synaptophysin (show SYP Antibodies), and insulin (show INS Antibodies) were ultrastructurally studied with the immunogold technique in porcine and human pancreatic islet neuroendocrine cells

Cow (Bovine) Chromogranin A (CHGA) interaction partners

  1. Vasoconstriction-Inhibiting Factor (VIF (show BTG1 Antibodies)), a degradation product of chromogranin A, is a vasoregulatory peptide that modulates the vasoconstrictive effects of angiotensin II by acting on the angiotensin II type 2 receptor (show AGTR2 Antibodies).

  2. chromogranin A has a role in the IP(3)-mediated Ca(2 (show CA2 Antibodies)+) release mechanism of secretory granules

  3. chromogranin A has a specific site in the N-terminal domain that can bind membrane lipids from different species

  4. role of coupling with the inositol 1,4,5-trisphosphate receptor/Ca2 (show CA2 Antibodies)+ channel (InsP3R (show ITPR1 Antibodies))in the Ca2 (show CA2 Antibodies)+-dependent ciliary movement

  5. involvement of CGA (show CGA Antibodies) with other components of the senile plaque

  6. significant species differences in vasoactivity of the N-terminal domain of ChgA

  7. determination of the subcellular distribution of chromogranins A and B in chromaffin cells; results suggest that chromogranins are at the center of intracellular Ca(2 (show CA2 Antibodies)+) homeostasis in secretory cells

Chromogranin A (CHGA) Antigen Profile

Antigen Summary

The protein encoded by this gene is a member of the chromogranin/secretogranin family of neuroendocrine secretory proteins. It is found in secretory vesicles of neurons and endocrine cells. This gene product is a precursor to three biologically active peptides\; vasostatin, pancreastatin, and parastatin. These peptides act as autocrine or paracrine negative modulators of the neuroendocrine system. Other peptides, including chromostatin, beta-granin, WE-14 and GE-25, are also derived from the full-length protein. However, biological activities for these molecules have not been shown.

Alternative names and synonyms associated with Chromogranin A (CHGA)

  • chromogranin A (chga) antibody
  • chromogranin A (CHGA) antibody
  • chromogranin A (Chga) antibody
  • chromogranin A (parathyroid secretory protein 1) (CHGA) antibody
  • chromogranin A (parathyroid secretory protein 1) (Chga) antibody
  • cgA antibody
  • CHGA antibody
  • ChrA antibody
  • fj05f09 antibody
  • si:dkey-177p2.2 antibody
  • wu:fj05f09 antibody
  • zgc:56075 antibody
  • zgc:101749 antibody

Protein level used designations for anti-Chromogranin A (CHGA) Antibodies

chromogranin-A , chromogranin A , cgA , SP-I , betagranin (N-terminal fragment of chromogranin A) , parathyroid secretory protein 1 , pituitary secretory protein I , pancreastatin

GENE ID SPECIES
450039 Danio rerio
574388 Macaca mulatta
12652 Mus musculus
1113 Homo sapiens
397540 Sus scrofa
24258 Rattus norvegicus
607527 Canis lupus familiaris
281070 Bos taurus
100717887 Cavia porcellus
100033828 Equus caballus
423420 Gallus gallus
Selected quality suppliers for anti-Chromogranin A (CHGA) Antibodies
Did you look for something else?